B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 8.51 HKD 0.24% Market Closed
Market Cap: 7.1B HKD

Relative Value

The Relative Value of one Beijing Tong Ren Tang Chinese Medicine Co Ltd stock under the Base Case scenario is 10.27 HKD. Compared to the current market price of 8.51 HKD, Beijing Tong Ren Tang Chinese Medicine Co Ltd is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
10.27 HKD
Undervaluation 17%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
25
Median 3Y
5.2
Median 5Y
5.4
Industry
2.6
Forward
4
vs History
85
vs Industry
31
Median 3Y
14.8
Median 5Y
14.7
Industry
21.6
Forward
12.6
vs History
63
vs Industry
26
Median 3Y
13.5
Median 5Y
14.1
Industry
16.5
vs History
60
vs Industry
22
Median 3Y
17
Median 5Y
17.1
Industry
22.5
vs History
93
vs Industry
40
Median 3Y
2
Median 5Y
2.4
Industry
2.3
vs History
92
vs Industry
30
Median 3Y
3.8
Median 5Y
4
Industry
2.9
Forward
3.3
vs History
77
vs Industry
36
Median 3Y
5.8
Median 5Y
5.9
Industry
5.5
vs History
30
vs Industry
33
Median 3Y
9.7
Median 5Y
9
Industry
13
Forward
7.6
vs History
39
vs Industry
37
Median 3Y
10.1
Median 5Y
9.7
Industry
16.6
Forward
8.7
vs History
61
vs Industry
35
Median 3Y
11.2
Median 5Y
11.3
Industry
15.8
vs History
60
vs Industry
28
Median 3Y
12
Median 5Y
12.3
Industry
19.1
vs History
93
vs Industry
31
Median 3Y
3.2
Median 5Y
3.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Beijing Tong Ren Tang Chinese Medicine Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
HK
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
7.1B HKD 4.2 13.8 10 10
US
Eli Lilly and Co
NYSE:LLY
985.4B USD 16.6 53.5 35.9 38.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
506.1B USD 5.5 20.1 16.5 21.4
CH
Roche Holding AG
SIX:ROG
251.4B CHF 4.1 26.7 11.4 13.3
UK
AstraZeneca PLC
LSE:AZN
209.2B GBP 4.8 29.8 107.9 157.9
CH
Novartis AG
SIX:NOVN
206.7B CHF 4.6 18 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
246.7B USD 3.8 13 9.2 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.2 10.7
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
142.4B USD 2.3 14.5 7.4 10.1
P/E Multiple
Earnings Growth PEG
HK
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Average P/E: 22.5
13.8
15%
0.9
US
Eli Lilly and Co
NYSE:LLY
53.5
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.7
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.8
38%
0.8
CH
Novartis AG
SIX:NOVN
18
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
HK
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Average EV/EBITDA: 399.7
10
17%
0.6
US
Eli Lilly and Co
NYSE:LLY
35.9
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.5
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.4
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
107.9
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4